Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
81M
-
Shares change
-
+2.92M
-
Total reported value, excl. options
-
$2.49B
-
Value change
-
+$38.9M
-
Put/Call ratio
-
0.95
-
Number of buys
-
79
-
Number of sells
-
-70
-
Price
-
$30.90
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q3 2019
166 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q3 2019.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81M shares
of 152M outstanding shares and own 53.36% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (38.4M shares), Matrix Capital Management Company, LP (17.3M shares), Senator Investment Group LP (5.11M shares), BlackRock Inc. (1.9M shares), VANGUARD GROUP INC (1.5M shares), BAKER BROS. ADVISORS LP (1.17M shares), TIGER MANAGEMENT L.L.C. (1.12M shares), TimesSquare Capital Management, LLC (1.1M shares), FRED ALGER MANAGEMENT, LLC (1.1M shares), and JPMORGAN CHASE & CO (871K shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.